🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Antiviral resistance remains an important issue for long-term NA therapy. F...
Status
Completed
Location
Department of Internal Medicine, Yonsei University College of Medicine
Start Date
2014-05-12
Trial ID
NCT02019966
This study evaluated the effects of a multidisciplinary biopsychosocial pro...
Status
Completed
Location
University Hospital Osijek
Start Date
2021-11-15
Trial ID
NCT07406711
Treatments Being Tested
This Phase Ib/II, open-label, multicenter trial is designed to evaluate the...
Status
Terminated
Location
Multiple Locations
Start Date
2006-06
Trial ID
NCT00400764
Treatments Being Tested
Patients with loco-regional NSCLC planned for curative treatment with chemo...
Status
Recruiting
Location
Odense University Hospital
Start Date
2015-08
Trial ID
NCT05258448
Treatments Being Tested
Background: Hypertriglyceridemia-associated acute pancreatitis (HTG-AP) has...
Status
Recruiting
Location
Department of Gastroenterology, Zhongshan Hospital, Xiamen University
Start Date
2026-01-18
Trial ID
NCT07720232
This study is a multicenter, prospective, randomized phase II trial aimed a...
Status
Recruiting
Location
Zhejiang Cancer Hospital
Start Date
2024-03-01
Trial ID
NCT06272214
Treatments Being Tested
To evaluate the safety and tolerance of the combination of adefovir dipivox...
Status
Completed
Location
Phoenix Body Positive
Start Date
TBD
Trial ID
NCT00002184
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as doxorubicin hydrochloride, b...
Status
Terminated
Location
Stanford Cancer Center
Start Date
2013-05-24
Trial ID
NCT01390584
This prospective cohort study aims to identify immune-related predictive fa...
Status
Active Not Recruiting
Location
Institute of Oncology Ljubljana
Start Date
2017-03-01
Trial ID
NCT07407244
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Status
Unknown
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-07
Trial ID
NCT00436709